Want to see HK:2190 full AI Analyst Report?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H (2190) Income Statement
Zylox-Tonbridge Medical Technology Co., Ltd. Class H Income Statement
Last quarter (Q2 2026), Zylox-Tonbridge Medical Technology Co., Ltd. Class H's total revenue was $632.04M, an increase of 72.69% from the same quarter last year. In Q2, Zylox-Tonbridge Medical Technology Co., Ltd. Class H's net income was $181.71M. See Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 1.06B | $ 782.48M | $ 527.75M | $ 334.09M | $ 177.91M | |
| $ 762.92M | $ 559.89M | $ 384.99M | $ 252.67M | $ 131.88M | |
| $ 562.65M | $ 499.02M | $ 541.51M | $ 474.86M | $ 349.94M | |
| Depreciation and Amortization | $ 37.27M | $ 37.85M | $ 35.88M | $ 26.27M | $ 13.38M |
| $ 236.08M | $ 74.03M | $ -41.60M | $ -86.56M | $ -204.78M | |
| $ 196.64M | $ 60.91M | $ -156.52M | $ -208.40M | $ -212.48M | |
| $ 33.97M | $ 39.34M | $ 77.79M | $ 94.84M | $ 12.79M | |
| $ 230.61M | $ 100.26M | $ -78.73M | $ -113.56M | $ -199.69M | |
| $ 244.37M | $ 100.26M | $ -78.73M | $ -113.56M | $ -199.69M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.76 | $ 0.31 | $ -0.24 | $ -0.34 | $ -0.68 |
| Diluted EPS | $ 0.76 | $ 0.31 | $ -0.24 | $ -0.34 | $ -0.68 |
| Weighted Average Shares Outstanding | 323.58M | 323.32M | 328.71M | 330.39M | 294.60M |
| Weighted Average Shares Outstanding (Diluted) | 323.60M | 327.99M | 328.71M | 330.39M | 294.60M |
Currency in CNY
